Appili Therapeutics Inc: INTERIM MDA EN

SEDARNov 14 08:27 ET · Announcements

Appili Therapeutics Inc: INTERIM FINANCIAL STATEMENTSREPORT EN

SEDARNov 14 08:27 ET · Announcements

Express News | Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025

ReutersNov 14 07:15 ET

Express News | Aditxt Provides Update on Equity Line of Credit, Atm Usage, and Outstanding Number of Shares

ReutersNov 8 08:31 ET

Express News | Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger With Aditxt's Subsidiary Adifem

ReutersNov 6 08:30 ET

Aditxt's Target Acquisition Appili Therapeutics Announces Alignment With FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission

BusinesswireOct 31 08:30 ET